StockMarketWire.com - Sunrise Resources said it had gleaned positive test results at its CS Pozzolan-Perlite project in Nevada.
Tests on the company's pozzolan show that the product mitigates the negative impact of concrete cancer.
The company had now received independent certification testwork results for three composite samples of its natural pozzolan demonstrating its effectiveness.
"This is a very important milestone in our testwork," chief executive Patrick Cheetham said.
"The CS pozzolan was tested using some of the most reactive aggregates known in the western USA."
At 1:49pm: [LON:SRES] Sunrise Resources PLC share price was +0.01p at 0.16p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.